Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 475

1.

Adenosquamous carcinoma arising in a duplication cyst of the gallbladder.

Ariche A, Schvimer M, Inbar Y, Dreznik Y.

Hepatobiliary Surg Nutr. 2018 Aug;7(4):317-319. doi: 10.21037/hbsn.2018.04.04. No abstract available.

2.

Complete portal vein occlusion after cyanoacrylate sclerotherapy in biliary atresia treated by living donor liver transplantation with intraoperative portal vein stenting via segment 4 portal vein stump.

Chen CL, Cheng YF, Ou HY, Yong CC, Lin TS, Wang SH, Lin CC, Concejero AM.

Hepatobiliary Surg Nutr. 2018 Aug;7(4):313-316. doi: 10.21037/hbsn.2018.04.03. No abstract available.

3.

Chronic non-communicable disease risks presented by lipid oxidation products in fried foods.

Grootveld M, Percival BC, Grootveld KL.

Hepatobiliary Surg Nutr. 2018 Aug;7(4):305-312. doi: 10.21037/hbsn.2018.04.01. No abstract available.

4.

Percutaneous ablation for HCC eligible to transplantation: providing more opportunities of remission in the context of graft shortage.

Nault JC, Nahon P, Séror O.

Hepatobiliary Surg Nutr. 2018 Aug;7(4):302-304. doi: 10.21037/hbsn.2018.06.01. No abstract available.

5.

Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: is it time to reconsider the current treatment guidelines?

Imai K, Baba H.

Hepatobiliary Surg Nutr. 2018 Aug;7(4):300-301. doi: 10.21037/hbsn.2018.05.02. No abstract available.

6.

Searching for common ground in a global disease.

Finn RS.

Hepatobiliary Surg Nutr. 2018 Aug;7(4):297-299. doi: 10.21037/hbsn.2018.04.06. No abstract available.

7.

Efficacy of radiofrequency ablation of hepatocellular carcinoma prior to liver transplantation and the need for competing-risk analysis.

Cucchetti A, Serenari M.

Hepatobiliary Surg Nutr. 2018 Aug;7(4):294-296. doi: 10.21037/hbsn.2018.04.05. No abstract available.

8.

Will the magnetic resonance imaging proton density fat fraction replace liver biopsy as the gold standard for detecting steatosis?

Yoneda M, Imajo K, Nakajima A.

Hepatobiliary Surg Nutr. 2018 Aug;7(4):292-293. doi: 10.21037/hbsn.2018.04.02. No abstract available.

9.

Neoadjuvant therapy for pancreatic ductal adenocarcinoma-real effects or patient selection?

Heinrich S.

Hepatobiliary Surg Nutr. 2018 Aug;7(4):289-291. doi: 10.21037/hbsn.2018.03.11. No abstract available.

10.

Laparoscopic liver resection: a review of current indications and surgical techniques.

Jia C, Li H, Wen N, Chen J, Wei Y, Li B.

Hepatobiliary Surg Nutr. 2018 Aug;7(4):277-288. doi: 10.21037/hbsn.2018.03.01. Review.

11.

Cohort contributions to trends in the incidence and mortality of intrahepatic cholangiocarcinoma.

Beal EW, Tumin D, Moris D, Zhang XF, Chakedis J, Dilhoff M, Schmidt CM, Pawlik TM.

Hepatobiliary Surg Nutr. 2018 Aug;7(4):270-276. doi: 10.21037/hbsn.2018.03.16.

12.

Effectiveness of additional resection of the invasive cancer-positive proximal bile duct margin in cases of hilar cholangiocarcinoma.

Ma WJ, Wu ZR, Shrestha A, Yang Q, Hu HJ, Wang JK, Liu F, Zhou RX, Li QS, Li FY.

Hepatobiliary Surg Nutr. 2018 Aug;7(4):251-269. doi: 10.21037/hbsn.2018.03.14.

13.

Synchronous colorectal liver metastases: a national survey of surgeon opinions on simultaneous resection and multidisciplinary cooperation.

Howard C, Clements TW, Edwards JP, MacLean AR, Buie WD, Dixon E, Grondin SC, Gomes A, McColl M, Cleary SP, Jayaraman S, Daigle R, Ball CG.

Hepatobiliary Surg Nutr. 2018 Aug;7(4):242-250. doi: 10.21037/hbsn.2017.12.01.

14.

Survival after resection of colorectal liver metastases in octogenarians and sexagenarians compared to their respective age-matched national population.

Brudvik KW, Røsok B, Naresh U, Yaqub S, Fretland ÅA, Labori KJ, Edwin B, Bjørnbeth BA.

Hepatobiliary Surg Nutr. 2018 Aug;7(4):234-241. doi: 10.21037/hbsn.2017.09.03.

15.

Use of robotics in liver donor right hepatectomy.

Di Benedetto F, Magistri P, Halazun KJ.

Hepatobiliary Surg Nutr. 2018 Jun;7(3):231-232. doi: 10.21037/hbsn.2018.03.10. No abstract available.

16.

Exploring new trends in living related liver transplantation.

Gruttadauria S, Pagano D.

Hepatobiliary Surg Nutr. 2018 Jun;7(3):229-230. doi: 10.21037/hbsn.2018.03.15. No abstract available.

17.

Fluids in abdominal surgery: what is the goal?

Eng OS.

Hepatobiliary Surg Nutr. 2018 Jun;7(3):227-228. doi: 10.21037/hbsn.2018.06.07. No abstract available.

18.

Restrictive versus liberal fluid therapy for major abdominal surgery: is the evidence strong?

Qiu Y, Yan X.

Hepatobiliary Surg Nutr. 2018 Jun;7(3):225-226. doi: 10.21037/hbsn.2018.06.05. No abstract available.

19.

The first-line treatment for unresectable hepatocellular carcinoma patients: lenvatinib versus sorafenib, or beyond?

Xie F, Feng S, Sun L, Mao Y.

Hepatobiliary Surg Nutr. 2018 Jun;7(3):221-224. doi: 10.21037/hbsn.2018.06.06. No abstract available.

20.

Enhanced recovery for liver resection-early recovery pathway for hepatectomy: data-driven liver resection care and recovery.

Morrison B, Kelliher L, Jones C.

Hepatobiliary Surg Nutr. 2018 Jun;7(3):217-220. doi: 10.21037/hbsn.2018.03.13. No abstract available.

Supplemental Content

Loading ...
Support Center